Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-010355·Serina Therapeutics, Inc.
Schedule 13D ownership disclosure
AGEX THERAPEUTICS INC
Security class unavailable · CUSIP: 00848H108
Event date: 2024-02-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 893,082,711
- Percent of class
- 80.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-010355
- Form type
- SC 13D/A
- Filer
- Serina Therapeutics, Inc.
- CIK
- CIK 1708599
- Filed
- Feb 05, 2024
- Reporting period
- Feb 01, 2024
- Description
- Schedule 13D beneficial ownership